0001596783-19-000025.txt : 20190325 0001596783-19-000025.hdr.sgml : 20190325 20190325175001 ACCESSION NUMBER: 0001596783-19-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190321 FILED AS OF DATE: 20190325 DATE AS OF CHANGE: 20190325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gennadios Aristippos CENTRAL INDEX KEY: 0001612357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 19703612 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_155355058624331.xml FORM 4 X0306 4 2019-03-21 0 0001596783 Catalent, Inc. CTLT 0001612357 Gennadios Aristippos C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 President, Softgel Tech. Common Stock 2019-03-21 4 M 0 13528 10.71 A 44862 D Common Stock 2019-03-21 4 F 0 5794 42.17 D 39068 D Common Stock 2019-03-21 4 F 0 950 42.16 D 38118 D Common Stock 2019-03-21 4 S 0 3326 42.17 D 34792 D Common Stock 2019-03-21 4 S 0 66 42.91 D 34726 D Options to purchase Common Stock 10.71 2019-03-21 4 M 0 13528 0 D 2016-09-09 2019-10-23 Common Stock 13528.0 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. Includes restricted stock units. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $41.84 to $42.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On October 23, 2009, the reporting person was granted options to purchase 23,240 shares of common stock of the Issuer, which partially vested and became exercisable based on satisfaction of certain performance-based vesting criteria on September 9, 2016. (S1116, S1159) /s/ Stephanie L. Mariconda, attorney-in-fact 2019-03-25